Tags : Obesity

Novo Nordisk Collaborates with Noom to Provide Digital Health Solutions

Shots: The companies collaborate on digital health solutions focusing on weight management and education with the goal of improving the lives of patients living with obesity The collaboration follows 8mos. pilot study which united Noom’s science-backed behavior change programs with Novo Nordisk’s 95yrs.+ experience will help to educate people with obesity to lose weight and […]Read More

Alytas Therapeutics Signs an Agreement with Velabs Therapeutics to Develop

Shots: Velabs and Alytas collaborated to jointly develop modulatory and functional Ab for a novel immune-based therapy against obesity utilizing Velabs’ microfluidic-based technology for rapid functional antibody screening Velabs to receive royalties on the global sales of the products resulting from the collaboration. The collaboration focuses to develop a new treatment for obesity to reduce […]Read More

Evotec and Novo Nordisk forms collaboration to develop novel small

Shots: The partnership will focus on indications like diabetes, obesity, co morbidities including nonalcoholic steatohepatitis (NASH), cardiovascular diseases, and diabetic kidney disease Evotec’s drug-discovery platform will be used in ligand-based design to produce products for patients Also the Evotec’s INDiGO platform will be used by Novo, to perform IND registration through pre-clinical studies. Financial details […]Read More